Is Abbott Laboratories Stock Underperforming the Nasdaq?

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products. Valued at $200.5 billion by market cap, ABT is a global leader in the large and growing in-vitro diagnostic market and its products include pharmaceuticals, nutritional, diagnostics, and vascular products. Companies worth $200 billion or more are generally described as “mega-cap stocks,” and ABT definitely fits that description, with its market cap exceeding this threshold, reflecting ...